Precision genome editing: A small revolution for glycobiology
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Precise and stable gene editing in mammalian cell lines has until recently been hampered by the lack of efficient targeting methods. While different gene silencing strategies have had tremendous impact on many biological fields, they have generally not been applied with wide success in the field of glycobiology, primarily due to their low efficiencies, with resultant failure to impose substantial phenotypic consequences upon the final glycosylation products. Here, we review novel nuclease-based precision genome editing techniques enabling efficient and stable gene editing, including gene disruption, insertion, repair, modification and deletion. The nuclease-based techniques comprised of homing endonucleases, zinc finger nucleases, transcription activator-like effector nucleases, as well as the RNA-guided clustered regularly interspaced short palindromic repeat/Cas nuclease system, all function by introducing single or double-stranded breaks at a defined genomic sequence. We here compare and contrast the different techniques and summarize their current applications, highlighting cases from the field of glycobiology as well as pointing to future opportunities. The emerging potential of precision gene editing for the field is exemplified by applications to xenotransplantation; to probing O-glycoproteomes, including differential O-GalNAc glycoproteomes, to decipher the function of individual polypeptide GalNAc-transferases, as well as for engineering Chinese Hamster Ovary host cells for production of improved therapeutic biologics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292 · cited 4×
“Several studies addressing CRISPR/Cas off-targets (Cradick et al. 2013; Fu et al. 2013; Hsu et al. 2013; Mali, Aach, et al. 2013; Pattanayak et al. 2013) suggest that on- and off-target rates are variable and difficult to predict and while impressive on-target activity can be achieved, off-targets with similar frequen…”
BackgroundInfluentialCRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153 · cited 3×
“…of species; however, despite continuously improved 665 Downloaded from https://academic.oup.com/glycob/article-abstract/24/8/663/2900476 by guest on 30 July 2018 platforms (Wilson et al. 2013), the design and selection of ZFNs with high cutting efficiency and specificity remains a challenge.”
BackgroundGenetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856 · cited 5×
“Alternatively, addition of proteasome inhibitors (Ramakrishna et al. 2013), cytostatic drugs (Rahman et al. 2012) or histone deacetylases (Pelascini et al. 2013) has been shown to improve ZFN activity.”
BackgroundMethodInfluentialPeptide and protein sequence analysis by electron transfer dissociation mass spectrometry
Syka, J. E. P., Coon, J. J., Schroeder, M. J., Shabanowitz, J., & Hunt, D. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402700101 · Cited by 2,370 · cited 2×
“…becoming addressable by improved mass spectrometry (MS) fragmentation strategies, particularly utilizing electron transfer dissociation (ETD) technology to enable sequencing of the protein backbone with minimal loss or fragmentation of the glycan entity (Syka et al. 2004; Hogan et al. 2005).”
BackgroundA TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098 · cited 2×
“…make DSB and various TALEN scaffolds consist of segments of the N- and C-terminal domain and usually between 15.5 and 19.5 RVDs, with the last module only containing 20 aa therefore designated as a half repeat (Christian et al. 2010; Miller et al. 2011; Mussolino et al. 2011; Bedell et al. 2012).”
BackgroundInfluentialImproving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · cited 2×
“2014) and modified sgRNA architecture (Pattanayak et al. 2013; Cho et al. 2014; Fu et al. 2014).”
MethodTargeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835 · cited 1×
“Therapeutic monoclonal antibodies carrying the core α6Fuc residue have substantially reduced antibody-dependent cellular cytotoxicity effects as first demonstrated for IgG1 produced in a CHO lectin-resistant mutant (Lec13) (Shields et al. 2002).”
Background
Cited by
Global view of human protein glycosylation pathways and functions
Schjoldager, K. T., Narimatsu, Y., Joshi, H. J., & Clausen, H. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00294-x · Cited by 1,309
Self-citationNarimatsu, Y., Joshi, H. J., Nason, R., Van Coillie, J., Karlsson, R., Sun, L., Ye, Z., Chen, Y.-H., Schjoldager, K. T., Steentoft, C., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.05.017 · Cited by 276
Self-citationEngineered CHO cells for production of diverse, homogeneous glycoproteins
Yang, Z., Wang, S., Halim, A., Schulz, M. A., Frodin, M., Rahman, S. H., Vester-Christensen, M. B., Behrens, C., Kristensen, C., Vakhrushev, S. Y., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3280 · Cited by 254
Goth, C. K., Halim, A., Khetarpal, S. A., Rader, D. J., Clausen, H., & Schjoldager, K. T.-B. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511175112 · Cited by 123
Self-citationAdvances in mass spectrometry driven O-glycoproteomics
Levery, S. B., Steentoft, C., Halim, A., Narimatsu, Y., Clausen, H., & Vakhrushev, S. Y. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.09.026 · Cited by 111
Self-citation
Metadata
- Authors
- Steentoft, C., Bennett, E. P., Schjoldager, K. T.-B. G., Vakhrushev, S. Y., Wandall, H. H., & Clausen, H.
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-05-26
- Volume
- 24
- Issue
- 8
- Pages
- 663-680
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- OpenAlex
- W2150221539
- Cited by
- 59
- References
- 45
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Precision genome editing: A small revolution for glycobiology. https://app.cochat.ai/papers/10.1093/glycob/cwu046
- The paper
- Steentoft, C., Bennett, E. P., Schjoldager, K. T.-B. G., Vakhrushev, S. Y., Wandall, H. H., & Clausen, H. (2014). Precision genome editing: A small revolution for glycobiology. Glycobiology. https://doi.org/10.1093/glycob/cwu046
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.